Hong-jun Li

Department of Urology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College,Beijing 100730,China

Management of Prostate Cancer:a Multidisciplinary Approachpublished by Springer provides an exhaustive review of the state of the art in the management of prostate cancer,from screening to treatment.The authors are all experts in their fields,and the editors are members of the European Organization for Research on Treatment of Cancer (EORTC),who have coordinated phase III EORTC trials and enjoy international reputation.A particualr feature of the monograph is the emphasis on the value of a multidisciplinary approach.The opening chapters address basic aspects including epidemiology,biology,and chemoprevention of prostate cancer.The role of individual and mass screening is carefully appraised,and diagnosis,clinical work-up,and the role of active surveillance are discussed in detail.Subsequent chapters are devot to the therapies that may be employed.Up to date data from clinical trials are included.In addition,the European Association of Urology(EAU) guidelines are presented and advice is given on the interpretation of results.

The book consists of 23 chapters,covering the following topics∶epidemiology of prostate cancer in Europe;chemoprevention of prostate cancer;individual and mass screening;anatomical pathology;biomarkers of prostate cancer;diagnosis,clinical work-up,TNM classification,markers;active surveillance for risk of prostate cancer∶background,patient selection,triggers for intervention,and outcomes;open radical prostatectomy;robot-assisted radical prostatectomy;permanent prostate brachytherapy;indications,technique,and results of high-dose-rate brachytherapy;intensity-modulated radiotherapy for prostate cancer;combination of androgen deprivation therapy and radiation therapy for locally advanced and localized prostate cancer;immediate or early delayed postoperative irradiation;high-intensity focused ultrasound for prostate cancer;cryotherapy;follow-up after radical treatments and relapse;first-line hormonal manipulation of prostate cancer;resistance to chemical castration and second-line hormonal treatment;targeted therapies and vaccination;how to interpret results;management of prostate cancer,EAU guidelines on screening,diagnosis,and treatment;better patients’ perspective.